University Of Notre Dame Du Lac Acadia Pharmaceuticals Inc Transaction History

University Of Notre Dame Du Lac

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $935,330 - $1.26 Million	-23,824 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$31.65 - $46.87 $88,809 - $131,517	2,806 Added 13.35%	23,824 $1.01 Million
Q4 2019 Feb 14, 2020	SELL	$36.21 - $51.4 $349,752 - $496,472	-9,659 Reduced 31.49%	21,018 $899,000
Q3 2019 Nov 13, 2019	SELL	$22.22 - $44.01 $2.53 Million - $5 Million	-113,641 Reduced 78.74%	30,677 $1.1 Million
Q2 2019 Aug 14, 2019	BUY	$23.32 - $28.12 $619,495 - $747,007	26,565 Added 22.56%	144,318 $3.86 Million
Q1 2019 May 15, 2019	SELL	$16.17 - $27.38 $149,750 - $253,566	-9,261 Reduced 7.29%	117,753 $3.16 Million
Q4 2018 Feb 13, 2019	BUY	$14.32 - $22.92 $1.82 Million - $2.91 Million	127,014 New	127,014 $2.05 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

Stay updated on University Of Notre Dame Du Lac with notifications on news.